Kenvue director granted 10,309 deferred share units
Sneed Michael E reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Sneed Michael E reported acquisition or exercise transactions in this Form 4 filing.
Kenvue Inc. director Michael E. Sneed received a grant of 10,309 Deferred Share Units at a reference price of $17.4600 per unit. Each DSU represents the right to receive one share of common stock, to be settled when his directorship ends. Following this award, he holds 36,626.663 DSUs, including units accumulated as dividend equivalents.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Deferred Share Units | 10,309 | $17.46 | $180K |
Footnotes (2)
- F1. Grant of Deferred Share Units ("DSUs") under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of Common Stock on the settlement date).
- F2. Includes DSUs acquired as dividend equivalents.
Key Figures
Key Terms
Amended and Restated Deferred Fee Plan for Directors financial
dividend equivalents financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Kenvue (KVUE) director Michael E. Sneed report on this Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.